J. Ashkenas

发表

Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes

S. Ross, H. Tildesley, J. Ashkenas, 2011, Current medical research and opinion.

Crafting science: A sociohistory of the quest for the genetics of cancer.

J. Ashkenas, 1997 .

Male infertility and the genetics of spermatogenesis.

J. Ashkenas, M. Ikawa, M. Okabe, 1998, American journal of human genetics.

GAMETOGENESIS '98 Male Infertility and the Genetics of Spermatogenesis

J. Ashkenas, M. Ikawa, M. Okabe, 1998 .

Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer

J. Ashkenas, H. Teoh, K. Barber, 2015, Journal of cutaneous medicine and surgery.

Gene regulation by mRNA editing.

J. Ashkenas, 1997, American journal of human genetics.

Structures and high and low affinity ligand binding properties of murine type I and type II macrophage scavenger receptors.

M. Freeman, M. Krieger, J. Ashkenas, 1993, Journal of lipid research.

Extracellular matrix remodeling and the regulation of epithelial-stromal interactions during differentiation and involution.

Z. Werb, M. Bissell, J. Ashkenas, 1996, Kidney international. Supplement.

Simple enzymatic means to neutralize DNA contamination in nucleic acid amplification.

J. Dennis, J. Ashkenas, C. Ho, 2005, BioTechniques.

Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors.

M. Krieger, J. Ashkenas, M. Penman, 1993, The Journal of biological chemistry.

Dry Eye Diseases and Ocular Surgery: Practical Guidelines for Canadian Eye Care Practitioners

J. Ashkenas, P. Karpecki, P. Harasymowycz, 2017 .

The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands.

M. Freeman, M. Krieger, J. Ashkenas, 1993, The Journal of biological chemistry.

INVITED EDITORIAL Williams Syndrome Starts Making Sense

J. Ashkenas, 2007 .

Practical Approaches to the Use of Lenalidomide in Multiple Myeloma: A Canadian Consensus

J. Ashkenas, D. Reece, M. Sebag, 2012, Advances in hematology.

The final stage of gene expression: chaperones and the regulation of protein fate.

P. Byers, J. Ashkenas, 1997, American journal of human genetics.

Proteolysis and the biochemistry of life-or-death decisions

Z. Werb, J. Ashkenas, Zena Werb, 1996, The Journal of experimental medicine.

Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis.

Z. Werb, J. Ashkenas, J. Wiesen, 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

J. Ashkenas, W. Gulliver, K. Papp, 2011, Journal of cutaneous medicine and surgery.

Obesity in South and Southeast Asia—A new consensus on care and management

J. Ashkenas, N. Somasundaram, B. Saboo, 2022, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses

J. Ashkenas, Y. Poulin, C. Lynde, 2015, Journal of cutaneous medicine and surgery.

The DNA mystique: The gene as a cultural icon.

J. Ashkenas, 1997 .

Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma

J. Ashkenas, Y. Poulin, P. Janiszewski, 2015, Journal of cutaneous medicine and surgery.

Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations

J. Ashkenas, K. Papp, M. Bourcier, 2011, Journal of cutaneous medicine and surgery.

Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus.

B. Leber, J. Ashkenas, J. Brandwein, 2013, American journal of blood research.

Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids.

J. Ashkenas, S. Kives, N. Leyland, 2020, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

LDLC encodes a brefeldin A-sensitive, peripheral Golgi protein required for normal Golgi function

M. Krieger, J. Ashkenas, P. Reddy, 1994, The Journal of cell biology.

The extracellular matrix in epithelial biology: shared molecules and common themes in distant phyla.

M. Bissell, J. Muschler, J. Ashkenas, 1996, Developmental biology.

An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors.

M. Freeman, N. Copeland, N. Jenkins, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Williams syndrome starts making sense.

J. Ashkenas, 1996, American journal of human genetics.

Epigenetics and its role in disease.

B. Tycko, J. Ashkenas, 2000, The Journal of clinical investigation.

INVITED EDITORIAL Gene Regulation by mRNA Editing

J. Ashkenas, 2006 .

Integrins, Signaling, and the Remodeling of the Extracellular Matrix

Z. Werb, M. Bissell, C. Damsky, 1994 .

Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys

J. Ashkenas, M. Gooderham, J. Rao, 2018, Journal of cutaneous medicine and surgery.

Psoriasis patients’ preference for an aerosol foam topical formulation

J. Ashkenas, M. Gooderham, J. Rao, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Pedigrees-publish? or perish the thought?

P. Byers, J. Ashkenas, 1998, American journal of human genetics.

Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines

J. Ashkenas, L. Guenther, C. Lynde, 2015, Journal of cutaneous medicine and surgery.

Duplex perception: Confirmation of fusion

B H Repp, B. Repp, J. Ashkenas, 1983, Perception & psychophysics.

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

J. Ashkenas, W. Gulliver, K. Papp, 2011, Journal of cutaneous medicine and surgery.

Physical and pharmacokinetic characterization of Soluvec™, a novel, solvent-free aqueous ivermectin formulation.

J. Ashkenas, Richa Mandalaywala, Azhar Rana, 2023, Therapeutic delivery.

Brief report Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes

S. Ross, H. Tildesley, J. Ashkenas, 2011 .